PIP Share Price

Open 3.10 Change Price %
High 3.10 1 Day -0.05 -1.61
Low 3.05 1 Week -0.05 -1.61
Close 3.05 1 Month 0.30 10.91
Volume 855280 1 Year 1.35 79.41
52 Week High 3.12
52 Week Low 1.38
PIP Important Levels
Resistance 2 3.10
Resistance 1 3.08
Pivot 3.07
Support 1 3.02
Support 2 3.00
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
CVM 0.11 -38.89%
CVM 0.11 -38.89%
PLX 0.31 -44.64%
PLX 0.31 -44.64%
RBY 0.03 -70.00%
NAK 1.45 21.85%
NAK 1.45 21.85%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
CMFO 0.12 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RVP 1.30 -46.94%
PLX 0.31 -44.64%
PLX 0.31 -44.64%
CVM 0.11 -38.89%
CVM 0.11 -38.89%
QBC 0.20 -33.33%
More..

PharmAthene, Inc (AMEX: PIP)

PIP Technical Analysis 5
As on 2nd Dec 2016 PIP Share Price closed @ 3.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.33 & Strong Buy for SHORT-TERM with Stoploss of 2.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
PIP Target for December
1st Target up-side 3.28
2nd Target up-side 3.44
3rd Target up-side 3.6
1st Target down-side 2.82
2nd Target down-side 2.66
3rd Target down-side 2.5
PIP Other Details
Segment EQ
Market Capital 50784284.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.pharmathene.com
PIP Address
PIP
One Park Place
Suite 450
Annapolis, MD 21401
United States
Phone: 410-269-2600
Fax: 410-269-2601
Interactive Technical Analysis Chart PharmAthene, Inc ( PIP AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PharmAthene, Inc
PIP Business Profile
PharmAthene, Inc., a biodefense company, develops and commercializes medical countermeasures against biological and chemical threats in the United States. Its product candidates include SparVax, a recombinant protective antigen anthrax vaccine for post-exposure prophylaxis in conjunction with antibiotics and general use prophylaxis; Valortim, a human monoclonal antibody to protect against and treat human inhalational anthrax; and recombinant butyrylcholinesterase bioscavenger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds comprising nerve gases and pesticides. The company serves the United States Department of Defense, Chemical Biological Medical Systems, Biomedical Advanced Research and Development Authority, the National Institute of Allergy and Infectious Diseases, and the National Institute of Health. It has collaboration with Bristol-Myers Squibb for developing Valortim. The company is headquartered in Annapolis, Maryland.